by adminTorusBrand | Oct 12, 2017 | HempMeds Mexico
[vc_row][vc_column][vc_column_text] Continued studies from Dr. Aguirre further reveal the advantages of a CBD treatment option for those suffering from seizures. Noted pediatric neurologist Dr. Carlos G. Aguirre-Velazquez today revealed the positive results of a...
by adminTorusBrand | Apr 5, 2017 | Company News, HempMeds Mexico
[vc_row][vc_column][vc_column_text] THC-free RSHO-X™ was at the center of an exciting new study looking at the effects of CBD on children with epilepsy. The study, performed by renowned physician Dr. Carlos Aguirre-Velazquez, surveyed parents in Mexico and the rest of...
by adminTorusBrand | May 2, 2018 | Company News
Medical Marijuana, Inc. portfolio company HempMeds® Brasil hosts CBD event at company’s San Diego home offices. Medical Marijuana, Inc. subsidiary HempMeds® Brasil invited doctors from Brazil to an educational symposium on CBD, scientific research, and best practices...
by adminTorusBrand | Nov 29, 2017 | Uncategorized
Medical Marijuana, Inc. subsidiary a Gold Sponsor of Expo Mede Weed medical cannabis conference. Held in Medellín, Colombia, from November 24-27, EXPO MEDE Weed is a premier international medical cannabis event hosted yearly to promote the knowledge and culture of the...
by adminTorusBrand | Oct 12, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Oct. 12, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the U.S., today announced that a recent clinical study conducted by renowned Mexico neurologist, Dr. Carlos G. Aguirre-Velazquez,...
